HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fang Wang Selected Research

Thyroid Dysgenesis (Thyroid Agenesis)

1/2022Nicotinamide nucleotide transhydrogenase mutation analysis in Chinese patients with thyroid dysgenesis.
1/2020DUOX2 and DUOXA2 Variants Confer Susceptibility to Thyroid Dysgenesis and Gland-in-situ With Congenital Hypothyroidism.
7/2017Next-generation sequencing of NKX2.1, FOXE1, PAX8, NKX2.5, and TSHR in 100 Chinese patients with congenital hypothyroidism and athyreosis.
1/2017Identification and characterization of novel PAX8 mutations in Congenital Hypothyroidism(CH) in a Chinese population.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Fang Wang Research Topics

Disease

569Neoplasms (Cancer)
10/2022 - 03/2002
139Inflammation (Inflammations)
10/2022 - 02/2003
100Infections
10/2022 - 03/2003
80Breast Neoplasms (Breast Cancer)
03/2022 - 03/2002
66Hepatocellular Carcinoma (Hepatoma)
01/2022 - 07/2005
65Neoplasm Metastasis (Metastasis)
05/2022 - 10/2003
58Carcinogenesis
04/2022 - 02/2004
56Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2022 - 10/2010
43Stomach Neoplasms (Stomach Cancer)
05/2022 - 10/2010
40Lung Neoplasms (Lung Cancer)
01/2022 - 04/2007
36Insulin Resistance
01/2022 - 07/2008
35Hypoxia (Hypoxemia)
11/2022 - 01/2011
35Body Weight (Weight, Body)
10/2022 - 09/2003
35Fibrosis (Cirrhosis)
04/2022 - 11/2008
34Colorectal Neoplasms (Colorectal Cancer)
05/2022 - 02/2004
34Type 2 Diabetes Mellitus (MODY)
01/2022 - 10/2009
33Ovarian Neoplasms (Ovarian Cancer)
10/2022 - 11/2003
30Ischemia
02/2022 - 03/2005
29Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 09/2006
29Carcinoma (Carcinomatosis)
01/2022 - 03/2002
29Proteinuria
01/2022 - 01/2007
29Obesity
11/2021 - 04/2006
28Cognitive Dysfunction
07/2022 - 03/2007
27Rheumatoid Arthritis
09/2022 - 06/2009
27Neural Tube Defects (Exencephaly)
12/2021 - 02/2008
26Pain (Aches)
01/2022 - 09/2006
26Parkinson Disease (Parkinson's Disease)
10/2021 - 05/2005
25Hyperglycemia
01/2022 - 03/2007
24Hypertension (High Blood Pressure)
11/2022 - 11/2003
24Wounds and Injuries (Trauma)
10/2022 - 06/2008
23Glioma (Gliomas)
06/2022 - 02/2005
23Heart Failure
01/2022 - 01/2005
22Reperfusion Injury
01/2022 - 08/2003
21COVID-19
10/2022 - 01/2020
21Stroke (Strokes)
07/2022 - 01/2010
21Alzheimer Disease (Alzheimer's Disease)
01/2022 - 03/2010
20Prostatic Neoplasms (Prostate Cancer)
07/2022 - 03/2005
20Necrosis
06/2022 - 09/2006
20Adenocarcinoma of Lung
01/2022 - 01/2005
20Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2022 - 06/2011
19Leukemia
05/2022 - 12/2003
19Diabetic Retinopathy (Retinopathy, Diabetic)
01/2022 - 05/2006
19Hereditary Nephritis (Alport Syndrome)
11/2021 - 04/2004
16Brain Ischemia (Cerebral Ischemia)
01/2023 - 10/2003
16Chronic Renal Insufficiency
12/2022 - 09/2011
16Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2022 - 03/2012
16Pre-Eclampsia (Preeclampsia)
12/2021 - 09/2010
16Myocardial Infarction
12/2021 - 02/2006
16Atherosclerosis
06/2021 - 02/2008

Drug/Important Bio-Agent (IBA)

225Proteins (Proteins, Gene)FDA Link
11/2022 - 12/2003
111Biomarkers (Surrogate Marker)IBA
05/2022 - 02/2004
94Pharmaceutical PreparationsIBA
01/2023 - 05/2005
93MicroRNAs (MicroRNA)IBA
01/2022 - 10/2006
82Messenger RNA (mRNA)IBA
11/2022 - 10/2003
67Biological ProductsIBA
08/2022 - 12/2003
56Long Noncoding RNAIBA
01/2022 - 11/2011
53CytokinesIBA
01/2022 - 06/2008
53Glucose (Dextrose)FDA LinkGeneric
01/2022 - 09/2006
41DNA (Deoxyribonucleic Acid)IBA
01/2022 - 10/2003
39Therapeutic UsesIBA
07/2022 - 09/2006
37EnzymesIBA
10/2022 - 04/2006
33RNA (Ribonucleic Acid)IBA
10/2022 - 04/2005
33Interleukin-6 (Interleukin 6)IBA
06/2022 - 01/2012
32LipidsIBA
01/2022 - 02/2008
30Insulin (Novolin)FDA Link
07/2022 - 07/2008
30ErbB Receptors (EGF Receptor)IBA
08/2021 - 08/2008
30AntigensIBA
04/2021 - 09/2003
29Small Interfering RNA (siRNA)IBA
06/2022 - 09/2006
27AntioxidantsIBA
06/2022 - 03/2006
26Peptides (Polypeptides)IBA
09/2022 - 04/2004
26Phosphotransferases (Kinase)IBA
07/2021 - 02/2006
25CreatinineIBA
12/2022 - 01/2007
25Tyrosine Kinase InhibitorsIBA
10/2021 - 10/2010
24Circular RNAIBA
12/2022 - 09/2017
24Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2021 - 10/2003
23VaccinesIBA
09/2022 - 09/2005
23AntibodiesIBA
06/2022 - 11/2003
23Cisplatin (Platino)FDA LinkGeneric
02/2022 - 08/2009
22LigandsIBA
06/2022 - 11/2006
21Adenosine Triphosphate (ATP)IBA
05/2022 - 02/2011
21AlbuminsIBA
02/2022 - 09/2003
21Retinaldehyde (Retinal)IBA
10/2021 - 01/2011
20Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2022 - 05/2007
19Reactive Oxygen Species (Oxygen Radicals)IBA
01/2023 - 12/2008
19Cadherins (E-Cadherin)IBA
01/2022 - 10/2003
19CateninsIBA
10/2021 - 06/2008
19Paclitaxel (Taxol)FDA LinkGeneric
01/2021 - 06/2003
18Indicators and Reagents (Reagents)IBA
12/2022 - 04/2006
17ATP-Binding Cassette Transporters (ABC Transporters)IBA
08/2022 - 02/2011
17CollagenIBA
02/2022 - 11/2007
17Antiviral Agents (Antivirals)IBA
01/2022 - 12/2003
17Neuroprotective AgentsIBA
01/2022 - 08/2009
16Immune Checkpoint InhibitorsIBA
01/2022 - 01/2018
16Transcription Factors (Transcription Factor)IBA
01/2022 - 01/2011

Therapy/Procedure

268Therapeutics
01/2023 - 09/2003
90Drug Therapy (Chemotherapy)
01/2022 - 05/2009
41Immunotherapy
01/2022 - 06/2007
36Radiotherapy
10/2022 - 05/2009
25Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2022 - 09/2006
16Transplantation
01/2022 - 01/2011